The response to substandard and falsified medical products in francophone sub-Saharan African countries: weaknesses and opportunities

References

• Nayyar GML, Breman JG, Mackey TK, et al.Falsified and substandard drugs: stopping the pandemicAm J Trop Med Hyg201910010581065 10.4269/ajtmh.18-0981 30860016 6493938
   PubMed Web of Science ®Google Scholar
• Newton PN, Bond KCon behalf of the Oxford Statement signatoriesGlobal access to quality-assured medical products: the Oxford Statement and call to actionLancet Glob Health20197e1609e1611 10.1016/S2214-109X(19)30426-7 31708137
   PubMed Web of Science ®Google Scholar
• Newton PN, Caillet C, Guerin PJA link between poor quality antimalarials and malaria drug resistance?Expert Rev Anti Infect Ther201614531533 1:CAS:528:DC%2BC28XosFejtb8%3D 10.1080/14787210.2016.1187560 27187060
   PubMed Web of Science ®Google Scholar
• Ozawa S, Evans DR, Bessias S, et al.Prevalence and estimated economic burden of substandard and falsified medicines in low- and middle-income countries: a systematic review and meta-analysisJAMA Netw Open20181 10.1001/jamanetworkopen.2018.1662 30646106 6324280
   PubMed Web of Science ®Google Scholar
• West African Health Organization Strategic Plan 2016–2020. https://www.wahooas.org/web-ooas/. Accessed 27 Apr 2023.
   Google Scholar
• The Extraordinary Meeting of the Assembly of ECOWAS Health Ministers and the High-Level Summit on Universal Health Coverage in Accra, Ghana. https://www.wahooas.org/web-ooas/en/mediatheque/articles/extraordinary-meeting-assembly-ecowas-health-ministers-and-high-level-summit. Accessed 31 May 2023.
   Google Scholar
• African Medicines Quality Forum Technical Committee (AMQF-TC), AUDA-NEPAD-AMRH. Accessed on 5/10/2023 at https://amrh.nepad.org/african-medicines-quality-forum-technical-committee-amqf-tc.
   Google Scholar
• ECOWAS Ministers adopt Action Plan to Address Illicit Drug Trafficking, Organized Crimes and Drug Abuse in West Africa, Economic Community of West African States (ECOWAS). Accessed on 5/10/2023 at https://edup.ecowas.int/the-ministerialmeeting-on-the-ecowas-drug-action-plan-2016-2020/.
   Google Scholar
• Amari ASG, Ouattara S, Koffi AADescriptive study of the regulation N°06/2010/CM/UEMOA on procedures followed for registration of pharmaceuticals for human use in UEMOA member statesLe Mali Med2012272612 1:STN:280:DC%2BB3c7it1KisQ%3D%3D
   PubMedGoogle Scholar
• Ncube BM, Dube A, Ward KThe domestication of the African union model law on medical products regulation: perceived benefits, enabling factors, and challengesFront Med2023 10.3389/fmed.2023.1117439
   Web of Science ®Google Scholar
• The Medicrime convention. MEDICRIME convention. https://www.coe.int. Accessed 26 Apr 2023.
   Google Scholar
• World Health Organization (WHO) member state mechanism. WHO Member State Mechanism. Accessed 5 October 2023 at https://www.who.int/teams/regulation-prequalification/incidents-and-SF/mechanism.
   Google Scholar
• Macé C, Rägo L, Ravinetto RHow the concept of WHO-listed authorities will change international procurement policies for medicinesBMJ Glob Health20226 10.1136/bmjgh-2021-008109 35144982 8883025
   PubMed Web of Science ®Google Scholar
• World Health Organization. A study on the public health and socioeconomic impact of substandard and falsified medical products. 2017. https://www.who.int/medicines/regulation/ssffc/publications/SE-Study_EN_web.pdf?ua=1. Accessed 12 Sept 2021.
   Google Scholar
• https://www.who.int/teams/regulation-prequalification/incidents-and-SF/full-list-of-who-medical-product-alerts. Accessed 15 June 2023.
   Google Scholar
• Kusynová Z, et al.Improved knowledge on SF medical products through a dedicated course for pharmacy students at three universities in sub-Saharan AfricaBMJ GH20236
   Google Scholar
• Ciza Hamuli P, Sacre P-Y, Kanyonyo MR, et al.Application of NIR handheld transmission spectroscopy and chemometrics to assess the quality of locally produced antimalarial medicines in the Democratic Republic of CongoTalanta Open.20213100025 10.1016/j.talo.2020.100025
   Google Scholar
• Ciza Hamuli P, Waffo Tchounga C, et al.Comparing the qualitative performances of handheld NIR and Raman spectrophotometers for the detection of falsified pharmaceutical productsTalanta2019202469478 10.1016/j.talanta.2019.04.049
   PubMed Web of Science ®Google Scholar
• Tchounga CW, Sacre PY, Ciza P, Ngono R, Ziemons E, Hubert P, Marini RDComposition analysis of falsified chloroquine phosphate samples seized during the COVID-19 pandemicJ Pharm Biomed Anal2020194113761 10.1016/j.jpba.2020.113761
   PubMed Web of Science ®Google Scholar
• The EPN GPHF MinilabTM Network. The Minilab Network, Ecumenical Pharmaceutical Network. https://epnetwork.org/. Accessed 24 Apr 2023.
   Google Scholar
• Mission for essential drugs and supplies (MEDS). https://meds.or.ke/. Accessed 24 Apr 2023.
   Google Scholar
• Schiavetti B, Wynendaele E, Melotte V, Van der Elst J, De Spiegeleer B, Ravinetto RA simplified checklist for the visual inspection of finished pharmaceutical products: a way to empower frontline health workers in the fight against poor-quality medicinesJ Pharm Policy Practice2020139 1:STN:280:DC%2BB38vjvVOrtA%3D%3D 10.1186/s40545-020-00211-9
   PubMed Web of Science ®Google Scholar
• Gnegel G, Häfele-Abah C, Neci R, Heide LSurveillance for substandard and falsified medicines by local faith-based organizations in 13 low- and middle-income countries using the GPHF MinilabSci Rep202212113095 1:CAS:528:DC%2BB38XitVChsbjM 10.1038/s41598-022-17123-0 35908047 9338985
   PubMed Web of Science ®Google Scholar
• Gnegel G, Hauk C, Neci R, et al.Identification of falsified chloroquine tablets in Africa at the time of the COVID-19 pandemicAm J Trop Med Hyg202010317376 1:CAS:528:DC%2BB38XhslaltL3N 10.4269/ajtmh.20-0363 32400349 7263564
   PubMed Web of Science ®Google Scholar
• Schäfermann S, Hauk C, Wemakor E, et al.Substandard and falsified antibiotics and medicines against noncommunicable diseases in Western Cameroon and Northeastern Democratic Republic of CongoAm J Trop Med Hyg20201032894908 10.4269/ajtmh.20-0184 32394884 7410427
   PubMed Web of Science ®Google Scholar
• El-Dahiyat F, Fahelelbom KM, Jairoun AA, Al-Hemyari SSCombatting substandard and falsified medicines: public awareness and identification of counterfeit medicationsFront Public Health2021 10.3389/fpubh.2021.754279 34765583 8575769
   PubMed Web of Science ®Google Scholar
• Ravinetto R, Vandenbergh D, Macé C, et al.Fighting poor-quality medicines in low- and middle-income countries: the importance of advocacy and pedagogyJ Pharm Policy Pract2016936 10.1186/s40545-016-0088-0 27843547 5105267
   PubMedGoogle Scholar